Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-05 5:26 pm Unchanged | 2021-04-05 | 13D | Agios Pharmaceuticals, Inc. AGIO | BRISTOL MYERS SQUIBB CO BMY | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-04-05 5:26 pm Purchase | 2019-11-20 | 13G | Jounce Therapeutics, Inc. JNCE | BRISTOL MYERS SQUIBB CO BMY | 3,456,463 7.600% | 3,456,463 (New Position) | Filing History |
| 2021-04-05 5:25 pm Purchase | 2021-03-25 | 13G | Ikena Oncology, Inc. IKNA | BRISTOL MYERS SQUIBB CO BMY | 2,133,142 5.900% | 2,133,142 (New Position) | Filing History |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Bristol-Myers Squibb Company BMY | VANGUARD GROUP INC | 199,340,458 8.820% | 4,480,304 (+2.30%) | Filing History |
| 2021-01-28 5:56 pm Purchase | 2020-12-31 | 13G | Bristol-Myers Squibb Company BMY | BlackRock Inc. BLK | 172,464,804 7.600% | 1,121,358 (+0.65%) | Filing History |
| 2020-07-16 5:01 pm Purchase | 2020-07-01 | 13D | Acceleron Pharma Inc. XLRN | BRISTOL MYERS SQUIBB CO BMY | 7,008,510 12.000% | 7,008,510 (New Position) | Filing History |